ACIDOSE LÁCTICA ASSOCIADA À METFORMINA – A HEMODIÁLISE ESTÁ INDICADA? | METFORMIN ASSOCIATED LACTIC ACIDOSIS – IS HEMODIALYSIS RECOMMENDED?

Raquel Maia, Énia Ornelas, Ramiro Carvalho

Resumo


PT | RESUMO
A metformina é uma biguanida oral universalmente utilizada no tratamento da diabetes mellitus tipo 2. A sua depuração
é maioritariamente renal e por isso deve ser usada com precaução nos doentes com doença renal. Elevadas concentrações
plasmáticas de metformina podem levar a acidose láctica grave. A acidose láctica associada à metformina (MALA) é uma
condição rara, mas potencialmente fatal. Como a metformina é altamente hidrossolúvel, pode ser removida por hemodiá-
lise, idealmente prolongada, para permitir a mobilização da forma intracelular. Da revisão da literatura, constatou-se que a
hemodiálise é mais eficaz que o tratamento de suporte em doentes com MALA. No entanto, estudos maiores são necessários
para reafirmar o benefício da diálise neste contexto.
Apresentamos o caso de um doente diabético com 70 anos de idade, em choque séptico e acidémia láctica grave, em que
apenas se observou correcção da acidose metabólica após a realização de técnica de substituição renal contínua.


Palavras-chave: Metformina; Acidose láctica; Hemodiálise; Diálise renal

 


EN | ABSTRACT
Metformin is an oral biguanide used worldwide in the treatment of diabetes mellitus type 2. As it is renally cleared it should be used
with caution in patients with renal impairment. Elevated plasma metformin concentrations, may lead to severe lactic acidosis. Metformin-
associated lactic acidosis (MALA) is a rare but potentially life-threatening condition. As metformin is highly water soluble, it can be removed
by hemodialysis if dialysis is conducted for long enough to mobilize the intracellular form. A literature review, found that dialysis techniques
proved to be better than supportive care, in MALA patients. Larger studies are needed to draw firmer recommendations on the treatment of
MALA, especially concerning the possible beneficial effects of dialysis in this context.
We report on a 70-year-old male type 2 diabetic patient, who presented with septic shock and severe lactic acidemia, in which metabolic
acidosis was only corrected after performing continuous renal replacement therapy.


Keywords: Metformin; Lactic acidosis; Hemodialysis; Renal dialyses


Texto Completo:

PDF

Referências


Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective

Diabetes Study (UKPDS) Group. Lancet. 1998;352:854-65.

Seidowsky A, Nseir S, Houdret N, Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med. 2009;37:2191-6.

Finkle SN. Should dialysis be offered in all cases of metformin-associated lactic acidosis? Crit Care. 2009;13:110.

Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes

mellitus. Cochrane Database Syst Rev. 2010(1):CD002967.

Scale T, Harvey JN. Diabetes, metformin and lactic acidosis. Clin Endocrinol (Oxf). 2011;74:191-6.

Vecchio S, Protti A. Metformin-induced lactic acidosis: no one left behind. Crit Care. 2011;15:107.

Kajbaf F, Lalau JD. The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis.

BMC Pharmacol Toxicol. 2013;14:22.

Peters N, Jay N, Barraud D, Cravoisy A, Nace L, Bollaert PE, et al. Metformin-associated lactic acidosis in an intensive care unit. Crit Care.

;12:R149.

Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin. N Engl

J Med. 1998;338:265-6.

Calello DP, Liu KD, Wiegand TJ, Roberts DM, Lavergne V, Gosselin S, et al. Extracorporeal Treatment for Metformin Poisoning: Systematic

Review and Recommendations From the Extracorporeal Treatments in Poisoning Workgroup. Crit Care Med. 2015;43:1716-30.

Ferreira N, Fernandes L, Cardiga R, Zilhão C, Silvestre J, Póvoa P. (2015). Severe Metformin Associated Lactic Acidosis: a Case Series of an

Intensive Care Unit. International Archives of Medicine: Vol. 8 No. 235.


Apontamentos

  • Não há apontamentos.